GlassScriptPhysician profile
Anne Kobbermann
NPI 1093927436
$1,179.53
in general payments reported to CMS, 2019-2025
17 companies · $654 in 2025
The $654 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.83 · 2021: $81.52 · 2022: $136 · 2023: $63.63 · 2024: $194 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $476.08 | 2024-2025 | Restrata Wound Matrix |
| Hologic Sales and Service, LLC | $220.69 | 2024-2025 | Magseed, Trident Specimen Radiography System, Trunode |
| Elucent Medical | $82.55 | 2022 | |
| Tactile Systems Technology INC | $68.11 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Bard Peripheral Vascular, INC. | $66.64 | 2021 | |
| Dilon Technologies, INC. | $40.35 | 2021-2023 | Hemoblast Bellows |
| Kerecis Limited | $33.08 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $30.25 | 2025 | Lynparza, Keytruda |
| Stryker Corporation | $23.69 | 2022 | |
| Aroa Biosurgery Incorporated | $23.52 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $20.73 | 2025 | |
| Focal Therapeutics, INC. | $17.86 | 2019 | |
| Becton, Dickinson and Company | $17.01 | 2019 | |
| Sirius Medical Systems | $15.76 | 2024 | Pintuition |
| Olympus America INC. | $14.96 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.39 | 2024 | Enhertu |
| Innovation Technologies INC | $13.86 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Kobbermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.